Video

00:52:44

SVM-AVF Session: Anticoagulation in Special Populations

Feb 22, 2023
This joint SVM-AVF session addressed anticoagulation challenges across four complex patient groups. One talk reviewed DOAC do...
Video

00:48:17

Post-Thrombotic Syndrome: Mechanisms, Drugs and Devices

Feb 26, 2022
This session on post-thrombotic syndrome opened with mouse models showing that plasmin and MMP activation drive thrombus reso...
Video

01:05:18

Venous Thromboembolism: Devices, Biomarkers and Selective Stenting

Feb 25, 2022
This VTE session opened with a microfluidic vein chip modeling how valve cusp hydrodynamics and shear dependent Ace2 expressi...
Video

01:21:41

AVF Presidential Session: Committee Reports and Leadership

Feb 25, 2022
This presidential session reviewed a year of American Venous Forum committee work, including expanded research grants with Bo...
Video

01:02:16

Optimizing Venous Stenting: Trials, Design and Complications

Feb 24, 2022
This session on optimizing venous stenting outcomes opened with an update on the C-TRACT randomized trial testing iliac stent...
Video

01:01:15

AVF Core Values: Diversity and Equity in Venous Disease Care

Feb 24, 2022
This AVF Core Values session on diversity and equity opened with a review of Medicare and private payer coverage barriers for...
Video

01:27:45

Lessons from COVID-19: Trials, Coagulopathy and Crisis Response

Feb 23, 2022
This session on lessons from the COVID-19 epidemic opened with an NIH overview of the ACTIV platform trials, which found full...
PDF

AVF Focuses on Science: Research Updates and New Grants

Jun 1, 2021
This June 2021 issue centers on AVF's scientific mission, opening with the president's call to make research the society's de...
Video

00:39:32

SVM-AVF Session: COVID Clots, Edema and Thrombophilia

Mar 20, 2021
This joint Society for Vascular Medicine and American Venous Forum session opened with Covid 19 thromboinflammation research...
Video

00:37:19

Innovation Session: Valves, Stents, Thrombectomy and Research

Mar 17, 2021
This innovation module opened with two venous valve devices finally reaching patients, the percutaneous Blue Leaf system and...
Video

00:31:44

Pandemic Lessons: Telemedicine, Coagulopathy and Lymphatics

Mar 17, 2021
This Day of Science module on pandemic lessons opened with data showing telemedicine visits improved access, cut travel burde...
Video

00:17:27

COVID-19 and VTE: Prognostic Markers to Anticoagulation Protocols

Mar 17, 2021
This invited lecture by Gino Merli reviewed how COVID-19 coagulopathy is marked by rising D-dimer, IL-6, LDH, and troponin le...
Video

00:30:31

COVID-19 Session: Anticoagulation, VTE Burden and Resources

Mar 17, 2021
This opening session at the virtual 33rd AVF meeting focused on COVID-19 and venous thromboembolism. A quality project found...

Result per page33-45 of 45

Browse Channels

Related

SVM-AVF Session: Anticoagulation in Special Populations

Post-Thrombotic Syndrome: Mechanisms, Drugs and Devices

Venous Thromboembolism: Devices, Biomarkers and Selective Stenting

AVF Presidential Session: Committee Reports and Leadership

Optimizing Venous Stenting: Trials, Design and Complications

AVF Core Values: Diversity and Equity in Venous Disease Care

Lessons from COVID-19: Trials, Coagulopathy and Crisis Response

AVF Focuses on Science: Research Updates and New Grants

SVM-AVF Session: COVID Clots, Edema and Thrombophilia

Innovation Session: Valves, Stents, Thrombectomy and Research

Pandemic Lessons: Telemedicine, Coagulopathy and Lymphatics

COVID-19 and VTE: Prognostic Markers to Anticoagulation Protocols

COVID-19 Session: Anticoagulation, VTE Burden and Resources